Trials / Suspended
SuspendedNCT02930499
Effect of Hyaluronic Acid ECM on Venous Ulcers
A Prospective, Randomized, Controlled, Longitudinal Study Using Repeated Measures Design to Evaluate a Hyaluronic Acid Extracellular Matrix (Hyalomatrix®) in the Management of Chronic Venous Ulcers
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Calvary Hospital, Bronx, NY · Academic / Other
- Sex
- All
- Age
- 21 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to compare the incidence and rate of wound healing in subjects with venous ulcers treated with an extracellular matrix composed of hyaluronic acid plus compression therapy as compared to standard care. The study also intends to follow the subjects for a 16-week period in order to evaluate ulcer recurrence within treatment groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyalomatrix extra-cellular matrix | An exta-cellular matrix made from hyaluronic acid |
| DEVICE | Mepilex wound dressing | A siliconized non-adhesive foam wound dressing |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-07-01
- Completion
- 2018-12-01
- First posted
- 2016-10-12
- Last updated
- 2017-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02930499. Inclusion in this directory is not an endorsement.